Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.29
+0.05 (0.95%)
Apr 25, 2025, 11:30 AM EDT - Market open
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $468.71 million as of April 25, 2025. Its market cap has increased by 157.06% in one year.
Market Cap
468.71M
Enterprise Value
289.76M
1-Year Change
157.06%
Ranking
Category
Stock Price
$5.29
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $468.71M, a decrease of -56.16%. That is a compound annual growth rate of -22.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 448.33M | 74.21% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.29B |
| UnitedHealth Group | 388.76B |
| Johnson & Johnson | 371.96B |
| AbbVie | 319.69B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.37B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |